首页 > 最新文献

Seminars in Pediatric Surgery最新文献

英文 中文
Impact of enhanced recovery after surgery (ERAS) on surgical site infections in pediatric surgery. 小儿外科手术后增强恢复对手术部位感染的影响。
IF 2.5 3区 医学 Q3 PEDIATRICS Pub Date : 2026-02-03 DOI: 10.1016/j.sempedsurg.2026.151581
Alejandro O Chara, Jessica K Sims, Jonathan Niconchuk, Irving J Zamora

Enhanced recovery after surgery (ERAS) is a multidisciplinary, evidence-based protocol designed to standardize perioperative care, minimize complications, and optimize recovery. While ERAS has demonstrated significant benefits in adult populations, widespread adoption in pediatric surgery remains in progress. One of its central goals is reducing postoperative infections, particularly surgical site infections (SSIs), which represent a common source of morbidity in children. Core ERAS elements-including perioperative nutrition, glycemic control, fluid and temperature management, antibiotic prophylaxis, wound care, device removal, and early mobilization-directly or indirectly influence infection risk. Although pediatric-specific data remain limited, growing evidence supports that ERAS protocols are safe and may reduce SSI incidence. This narrative review outlines how individual ERAS components target SSI prevention, highlights current pediatric evidence, and identifies knowledge gaps where further research is needed to optimize infection prevention strategies for children undergoing surgery.

术后增强恢复(ERAS)是一项多学科、基于证据的方案,旨在规范围手术期护理、减少并发症和优化恢复。虽然ERAS在成人人群中已显示出显著的益处,但在儿科手术中的广泛采用仍在进行中。其中心目标之一是减少术后感染,特别是手术部位感染(ssi),这是儿童发病率的常见来源。ERAS的核心要素——包括围手术期营养、血糖控制、液体和温度管理、抗生素预防、伤口护理、器械移除和早期动员——直接或间接影响感染风险。尽管儿科数据仍然有限,但越来越多的证据支持ERAS方案是安全的,可以减少SSI的发生率。这篇叙述性综述概述了各个ERAS组件如何针对SSI预防,强调了当前的儿科证据,并确定了需要进一步研究的知识空白,以优化手术儿童的感染预防策略。
{"title":"Impact of enhanced recovery after surgery (ERAS) on surgical site infections in pediatric surgery.","authors":"Alejandro O Chara, Jessica K Sims, Jonathan Niconchuk, Irving J Zamora","doi":"10.1016/j.sempedsurg.2026.151581","DOIUrl":"https://doi.org/10.1016/j.sempedsurg.2026.151581","url":null,"abstract":"<p><p>Enhanced recovery after surgery (ERAS) is a multidisciplinary, evidence-based protocol designed to standardize perioperative care, minimize complications, and optimize recovery. While ERAS has demonstrated significant benefits in adult populations, widespread adoption in pediatric surgery remains in progress. One of its central goals is reducing postoperative infections, particularly surgical site infections (SSIs), which represent a common source of morbidity in children. Core ERAS elements-including perioperative nutrition, glycemic control, fluid and temperature management, antibiotic prophylaxis, wound care, device removal, and early mobilization-directly or indirectly influence infection risk. Although pediatric-specific data remain limited, growing evidence supports that ERAS protocols are safe and may reduce SSI incidence. This narrative review outlines how individual ERAS components target SSI prevention, highlights current pediatric evidence, and identifies knowledge gaps where further research is needed to optimize infection prevention strategies for children undergoing surgery.</p>","PeriodicalId":49543,"journal":{"name":"Seminars in Pediatric Surgery","volume":" ","pages":"151581"},"PeriodicalIF":2.5,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146144418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What should ethics guidelines look like for clinical trials of in utero stem cell, protein, mRNA, and gene therapies to treat fetal disease? 子宫内干细胞、蛋白质、mRNA和基因疗法治疗胎儿疾病的临床试验的伦理准则应该是什么样的?
IF 2.5 3区 医学 Q3 PEDIATRICS Pub Date : 2026-01-10 DOI: 10.1016/j.sempedsurg.2026.151579
Emily M Scire, Dario O Fauza

State-of-the-art minimally invasive in utero interventions involving stem cell, protein, and nucleic acid-based therapies represent a new frontier in medicine, which offers hope for devastating fetal diagnoses and promises the restoration of lifetimes. Yet they also introduce serious concerns regarding health risks posed to mother, fetus, and future generations. Recent international consensus statements provide general guidance for structuring trials to maximize health and minimize the risk of experimental treatments for both a pregnant mother and fetus. This article offers additional ethical guidance for translating interventions from first-in-human studies by focusing on a more holistic and nondirective consent process and encouraging pretrial publication of proposed studies to increase dialogue, fine-tune protocols, and potentially improve access.

最先进的微创子宫干预包括干细胞、蛋白质和核酸为基础的治疗代表了医学的新前沿,它为毁灭性的胎儿诊断提供了希望,并承诺恢复生命。然而,它们也引起了对母亲、胎儿和后代健康风险的严重关切。最近的国际共识声明为组织试验提供了一般指导,以最大限度地提高孕妇和胎儿的健康,并尽量减少实验性治疗的风险。本文通过关注更全面和非指导性的同意过程,并鼓励拟议研究的审前出版,以增加对话,微调协议,并潜在地改善获取,为从首次人体研究中翻译干预措施提供了额外的伦理指导。
{"title":"What should ethics guidelines look like for clinical trials of in utero stem cell, protein, mRNA, and gene therapies to treat fetal disease?","authors":"Emily M Scire, Dario O Fauza","doi":"10.1016/j.sempedsurg.2026.151579","DOIUrl":"https://doi.org/10.1016/j.sempedsurg.2026.151579","url":null,"abstract":"<p><p>State-of-the-art minimally invasive in utero interventions involving stem cell, protein, and nucleic acid-based therapies represent a new frontier in medicine, which offers hope for devastating fetal diagnoses and promises the restoration of lifetimes. Yet they also introduce serious concerns regarding health risks posed to mother, fetus, and future generations. Recent international consensus statements provide general guidance for structuring trials to maximize health and minimize the risk of experimental treatments for both a pregnant mother and fetus. This article offers additional ethical guidance for translating interventions from first-in-human studies by focusing on a more holistic and nondirective consent process and encouraging pretrial publication of proposed studies to increase dialogue, fine-tune protocols, and potentially improve access.</p>","PeriodicalId":49543,"journal":{"name":"Seminars in Pediatric Surgery","volume":" ","pages":"151579"},"PeriodicalIF":2.5,"publicationDate":"2026-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146041894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From the editor: ethics of pediatric surgical innovation. 来自编者:儿科外科创新伦理。
IF 2.5 3区 医学 Q3 PEDIATRICS Pub Date : 2026-01-10 DOI: 10.1016/j.sempedsurg.2026.151580
Emily M Scire, Dario O Fauza
{"title":"From the editor: ethics of pediatric surgical innovation.","authors":"Emily M Scire, Dario O Fauza","doi":"10.1016/j.sempedsurg.2026.151580","DOIUrl":"https://doi.org/10.1016/j.sempedsurg.2026.151580","url":null,"abstract":"","PeriodicalId":49543,"journal":{"name":"Seminars in Pediatric Surgery","volume":" ","pages":"151580"},"PeriodicalIF":2.5,"publicationDate":"2026-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146020453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infections in pediatric extracorporeal life support. 儿童体外生命维持系统感染。
IF 2.5 3区 医学 Q3 PEDIATRICS Pub Date : 2025-12-30 DOI: 10.1016/j.sempedsurg.2025.151578
Vikas S Gupta, Joseph T Church, Kevin N Johnson
{"title":"Infections in pediatric extracorporeal life support.","authors":"Vikas S Gupta, Joseph T Church, Kevin N Johnson","doi":"10.1016/j.sempedsurg.2025.151578","DOIUrl":"https://doi.org/10.1016/j.sempedsurg.2025.151578","url":null,"abstract":"","PeriodicalId":49543,"journal":{"name":"Seminars in Pediatric Surgery","volume":" ","pages":"151578"},"PeriodicalIF":2.5,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145918868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence for prediction and detection of pediatric surgical site infection. 人工智能在小儿手术部位感染预测与检测中的应用。
IF 2.5 3区 医学 Q3 PEDIATRICS Pub Date : 2025-12-24 DOI: 10.1016/j.sempedsurg.2025.151577
Andrew P Bain, Jeffrey S Upperman

Surgical site infections (SSIs) remain a significant source of morbidity in pediatric surgery, prolonging hospital stays, increasing readmissions, and driving up healthcare costs. Manual chart reviews and static risk models limit traditional SSI prediction and detection. The rise of artificial intelligence (AI), including machine learning (ML), natural language processing (NLP), and large language models (LLMs), offers a transformative opportunity to enhance prediction and surveillance. This review synthesizes current literature on AI applications in pediatric SSI, emphasizing predictive models built on NSQIP-P data and detection strategies leveraging EHRs and wearable technologies. Despite encouraging retrospective results, real-world adoption remains constrained by poor validation, limited generalizability, and workflow misalignment. Ethical and regulatory concerns, including bias, transparency, and pediatric-specific data limitations, must be addressed to ensure safe, equitable implementation. Thoughtfully developed and deployed, AI-driven tools can transform pediatric surgical care by enabling earlier intervention and improving outcomes.

手术部位感染(ssi)仍然是儿科外科发病率的一个重要来源,它延长了住院时间,增加了再入院率,并推高了医疗成本。手工图表审查和静态风险模型限制了传统的SSI预测和检测。人工智能(AI)的兴起,包括机器学习(ML)、自然语言处理(NLP)和大型语言模型(llm),为增强预测和监控提供了一个变革性的机会。本文综述了人工智能在儿童SSI中的应用,强调了基于NSQIP-P数据的预测模型和利用电子病历和可穿戴技术的检测策略。尽管鼓舞了回顾性的结果,但现实世界的采用仍然受到验证不良、有限的通用性和工作流程不一致的限制。必须解决伦理和监管方面的问题,包括偏见、透明度和儿科特定数据限制,以确保安全、公平地实施。经过深思熟虑的开发和部署,人工智能驱动的工具可以通过早期干预和改善结果来改变儿科外科护理。
{"title":"Artificial intelligence for prediction and detection of pediatric surgical site infection.","authors":"Andrew P Bain, Jeffrey S Upperman","doi":"10.1016/j.sempedsurg.2025.151577","DOIUrl":"https://doi.org/10.1016/j.sempedsurg.2025.151577","url":null,"abstract":"<p><p>Surgical site infections (SSIs) remain a significant source of morbidity in pediatric surgery, prolonging hospital stays, increasing readmissions, and driving up healthcare costs. Manual chart reviews and static risk models limit traditional SSI prediction and detection. The rise of artificial intelligence (AI), including machine learning (ML), natural language processing (NLP), and large language models (LLMs), offers a transformative opportunity to enhance prediction and surveillance. This review synthesizes current literature on AI applications in pediatric SSI, emphasizing predictive models built on NSQIP-P data and detection strategies leveraging EHRs and wearable technologies. Despite encouraging retrospective results, real-world adoption remains constrained by poor validation, limited generalizability, and workflow misalignment. Ethical and regulatory concerns, including bias, transparency, and pediatric-specific data limitations, must be addressed to ensure safe, equitable implementation. Thoughtfully developed and deployed, AI-driven tools can transform pediatric surgical care by enabling earlier intervention and improving outcomes.</p>","PeriodicalId":49543,"journal":{"name":"Seminars in Pediatric Surgery","volume":" ","pages":"151577"},"PeriodicalIF":2.5,"publicationDate":"2025-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145897100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of caudal versus penile block on the incidence of hypospadias complications following primary repairs: A prospective, double-blind, randomized controlled trial. 尾侧阻滞与阴茎阻滞对尿道下裂初次修复后并发症发生率的影响:一项前瞻性、双盲、随机对照试验。
IF 2.5 3区 医学 Q3 PEDIATRICS Pub Date : 2025-11-19 DOI: 10.1016/j.sempedsurg.2025.151576
Fikret Salık, Meral Erdal Erbatur, Mehmet Ali Turgut, Zülfü Savaş, Ayhan Kaydu, Mehmet Hanifi Okur, Hakkari Aydogdu, Mustafa Azizoglu

Introduction: This prospective, randomized, double-blinded study aimed to compare the incidence of postoperative complications and perioperative analgesic efficacy between caudal and penile block in children undergoing primary hypospadias repair.

Methods: Sixty-two boys aged 6-48 months were randomly assigned to receive either caudal block group (CB, n = 31) or penile block group (PB, n = 31) for preemptive analgesia before surgery. All patients underwent tubularized incised plate urethroplasty. The primary outcome was the incidence of postoperative complications, including urethrocutaneous fistula and meatal stenosis, assessed at 3- and 6-months post-surgery. Secondary outcomes included total perioperative fentanyl consumption and the number of patients requiring rescue analgesia.

Results: There were no significant differences in the incidence of total complications (9.7 % vs. 16.1 %, p = 0.449), fistula (6.5 % vs. 3.2 %, p = 0.554), or meatal stenosis (3.2 % vs. 12.9 %, p = 0.162) between the CB and PB groups. However, fistula rate was significantly higher in patients with midpenil compared to distal hypospadias (13 % vs. 0 %, p = 0.021). Total perioperative fentanyl consumption and the number of patients requiring rescue analgesia were significantly lower in the CB group (p = 0.041 and p = 0.01, respectively).

Conclusion: In conclusion, caudal block provides superior perioperative analgesia without increasing the risk of postoperative complications compared to penile block in children undergoing primary hypospadias repair.

Level of evidence: Level I.

本前瞻性、随机、双盲研究旨在比较行原发性尿道下裂修复术的儿童行尾侧阻滞和阴茎阻滞的术后并发症发生率和围手术期镇痛疗效。方法:将62例6 ~ 48月龄男孩随机分为尾侧阻滞组(CB, n = 31)和阴茎阻滞组(PB, n = 31)进行术前先发制人镇痛。所有患者均行管状切开钢板尿道成形术。主要结果是术后并发症的发生率,包括尿道瘘和金属狭窄,在术后3个月和6个月进行评估。次要结局包括围手术期芬太尼总消耗量和需要急救镇痛的患者人数。结果:CB组与PB组总并发症发生率(9.7% vs. 16.1%, p = 0.449)、瘘管发生率(6.5% vs. 3.2%, p = 0.554)、狭窄发生率(3.2% vs. 12.9%, p = 0.162)差异均无统计学意义。然而,与远端尿道下裂相比,中阴茎组的瘘管发生率明显更高(13% vs. 0%, p = 0.021)。CB组围手术期芬太尼总用量和需要抢救性镇痛的患者数量显著低于对照组(p = 0.041和p = 0.01)。结论:与阴茎阻滞相比,尾侧阻滞在儿童原发性尿道下裂修复术中提供了更好的围术期镇痛,且不增加术后并发症的风险。证据等级:一级。
{"title":"Effects of caudal versus penile block on the incidence of hypospadias complications following primary repairs: A prospective, double-blind, randomized controlled trial.","authors":"Fikret Salık, Meral Erdal Erbatur, Mehmet Ali Turgut, Zülfü Savaş, Ayhan Kaydu, Mehmet Hanifi Okur, Hakkari Aydogdu, Mustafa Azizoglu","doi":"10.1016/j.sempedsurg.2025.151576","DOIUrl":"https://doi.org/10.1016/j.sempedsurg.2025.151576","url":null,"abstract":"<p><strong>Introduction: </strong>This prospective, randomized, double-blinded study aimed to compare the incidence of postoperative complications and perioperative analgesic efficacy between caudal and penile block in children undergoing primary hypospadias repair.</p><p><strong>Methods: </strong>Sixty-two boys aged 6-48 months were randomly assigned to receive either caudal block group (CB, n = 31) or penile block group (PB, n = 31) for preemptive analgesia before surgery. All patients underwent tubularized incised plate urethroplasty. The primary outcome was the incidence of postoperative complications, including urethrocutaneous fistula and meatal stenosis, assessed at 3- and 6-months post-surgery. Secondary outcomes included total perioperative fentanyl consumption and the number of patients requiring rescue analgesia.</p><p><strong>Results: </strong>There were no significant differences in the incidence of total complications (9.7 % vs. 16.1 %, p = 0.449), fistula (6.5 % vs. 3.2 %, p = 0.554), or meatal stenosis (3.2 % vs. 12.9 %, p = 0.162) between the CB and PB groups. However, fistula rate was significantly higher in patients with midpenil compared to distal hypospadias (13 % vs. 0 %, p = 0.021). Total perioperative fentanyl consumption and the number of patients requiring rescue analgesia were significantly lower in the CB group (p = 0.041 and p = 0.01, respectively).</p><p><strong>Conclusion: </strong>In conclusion, caudal block provides superior perioperative analgesia without increasing the risk of postoperative complications compared to penile block in children undergoing primary hypospadias repair.</p><p><strong>Level of evidence: </strong>Level I.</p>","PeriodicalId":49543,"journal":{"name":"Seminars in Pediatric Surgery","volume":" ","pages":"151576"},"PeriodicalIF":2.5,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145642328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of risk factors for poor incision healing after the Nuss procedure for pectus excavatum 漏斗胸Nuss手术后切口愈合不良的危险因素分析。
IF 2.5 3区 医学 Q3 PEDIATRICS Pub Date : 2025-11-01 DOI: 10.1016/j.sempedsurg.2025.151539
Xiaoyan Liu , Fan Yang , Zhenlei Jia , Ling Zhao , Zaili Chen , Youlei Wei , Fang Yue

Objective

To investigate the risk factors of postoperative poor incision healing in children with congenital pectus excavatum who underwent thoracoscopic-assisted Nuss procedure.

Methods

In this study, a retrospective cohort study method was adopted to statistically analyze the clinical data of children with congenital pectus excavatum who underwent thoracoscopic-assisted Nuss procedure from 2017 to 2024. The children were categorized into groups with good incision healing and groups with poor healing according to the criteria, and the risk factors that might affect the incision healing were collected, including gender, age, height, weight, BMI, HI, type of pectus excavatum, and previous allergy history, number of the Nuss bars, whether fixation piece was applied, fixation method, suture method, surgical time and bleeding amount.

Results

Based on the inclusion and exclusion criteria, a total of 272 children with Nuss procedure were collected, and during the follow-up period, 25 children experienced poor incision healing. Univariate and multivariate logistic regression analyses were performed in both groups, and the results showed that low BMI, asymmetric pectus excavatum, previous allergy history, wire-fixed bars, and intradermal sutures were independent risk factors for poor incisional healing after the Nuss procedure for pectus excavatum (all P < 0.05).

Conclusion

Poor postoperative incision healing is more likely to occur in children with low BMI, asymmetric pectus excavatum, previous allergy history, and children with intraoperative wire fixation of bars and intradermal sutures.
目的:探讨先天性漏斗胸患儿行胸腔镜辅助Nuss手术后切口愈合不良的危险因素。方法:本研究采用回顾性队列研究方法,统计分析2017 - 2024年胸腔镜辅助下Nuss手术治疗先天性漏斗胸患儿的临床资料。将患儿按标准分为切口愈合良好组和愈合不良组,收集可能影响切口愈合的危险因素,包括性别、年龄、身高、体重、BMI、HI、漏斗胸类型、既往过敏史、Nuss棒数量、是否使用固定片、固定方式、缝合方式、手术时间、出血量等。结果:根据纳入和排除标准,共收集Nuss手术患儿272例,随访期间切口愈合不良患儿25例。对两组患者进行单因素和多因素logistic回归分析,结果显示低BMI、不对称漏斗胸、既往过敏史、金属丝固定棒、皮内缝合是漏斗胸Nuss手术后切口愈合不良的独立危险因素(均P < 0.05)。结论:低BMI、漏斗胸不对称、既往有过敏史、术中铁丝固定棒及皮内缝合的患儿更易发生术后切口愈合不良。
{"title":"Analysis of risk factors for poor incision healing after the Nuss procedure for pectus excavatum","authors":"Xiaoyan Liu ,&nbsp;Fan Yang ,&nbsp;Zhenlei Jia ,&nbsp;Ling Zhao ,&nbsp;Zaili Chen ,&nbsp;Youlei Wei ,&nbsp;Fang Yue","doi":"10.1016/j.sempedsurg.2025.151539","DOIUrl":"10.1016/j.sempedsurg.2025.151539","url":null,"abstract":"<div><h3>Objective</h3><div>To investigate the risk factors of postoperative poor incision healing in children with congenital pectus excavatum who underwent thoracoscopic-assisted Nuss procedure.</div></div><div><h3>Methods</h3><div>In this study, a retrospective cohort study method was adopted to statistically analyze the clinical data of children with congenital pectus excavatum who underwent thoracoscopic-assisted Nuss procedure from 2017 to 2024. The children were categorized into groups with good incision healing and groups with poor healing according to the criteria, and the risk factors that might affect the incision healing were collected, including gender, age, height, weight, BMI, HI, type of pectus excavatum, and previous allergy history, number of the Nuss bars, whether fixation piece was applied, fixation method, suture method, surgical time and bleeding amount.</div></div><div><h3>Results</h3><div>Based on the inclusion and exclusion criteria, a total of 272 children with Nuss procedure were collected, and during the follow-up period, 25 children experienced poor incision healing. Univariate and multivariate logistic regression analyses were performed in both groups, and the results showed that low BMI, asymmetric pectus excavatum, previous allergy history, wire-fixed bars, and intradermal sutures were independent risk factors for poor incisional healing after the Nuss procedure for pectus excavatum (all <em>P</em> &lt; 0.05).</div></div><div><h3>Conclusion</h3><div>Poor postoperative incision healing is more likely to occur in children with low BMI, asymmetric pectus excavatum, previous allergy history, and children with intraoperative wire fixation of bars and intradermal sutures.</div></div>","PeriodicalId":49543,"journal":{"name":"Seminars in Pediatric Surgery","volume":"38 ","pages":"Article 151539"},"PeriodicalIF":2.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145245739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is age in children with Wilms tumour an important prognostic factor? 儿童Wilms肿瘤的年龄是一个重要的预后因素吗?
IF 2.5 3区 医学 Q3 PEDIATRICS Pub Date : 2025-11-01 DOI: 10.1016/j.sempedsurg.2025.151568
Marcin Polok , Bernarda Kazanowska , Ewa Bień , Aleksandra Karaczewska , Natalia Karkos , Wojciech Apoznański

Background

The aim of the study was an assessment of whether the age of patients with WT could be measured as a risk factor and an analysis of the treatment of patients over 10 years old.

Methods

The data of 942 patients treated because of Wilms tumour from 1997 to 2022 were assessed.

Results

Patients were divided by age into two groups: group 1 (888 (94,27%) patients age 0–9 years old) and group 2 (54 (5,73%) patients age 10–18 years old). In group 1, there were more patients at higher stage than in group 2 (p<0,05). The histology of low risk in group 1 versus group 2 occurred in 13,4% vs 3,7% patients, of intermediate risk in 66,2% vs 66,7% patients and high risk in 19,9% vs 29,6% patients. Results of treatment were assessed only in group 2 which is a limitation of this study. Overall 62,96% patients survived in this group.

Conclusion

Wilms tumour in children 10–18 years old is diagnosed at a higher stage and with worse histology. Overall survival in this age group is lower than in younger children, which is in line with the current literature.
背景:本研究的目的是评估WT患者的年龄是否可以作为一种危险因素,并分析10岁以上患者的治疗情况。方法:对1997 ~ 2022年因Wilms肿瘤治疗的942例患者的资料进行分析。结果:患者按年龄分为两组:1组888例(94.27%),年龄0 ~ 9岁;2组54例(5.73%),年龄10 ~ 18岁。结论:10 ~ 18岁儿童Wilms肿瘤分期较高,组织学较差。这一年龄组的总体生存率低于更年幼的儿童,这与目前的文献一致。
{"title":"Is age in children with Wilms tumour an important prognostic factor?","authors":"Marcin Polok ,&nbsp;Bernarda Kazanowska ,&nbsp;Ewa Bień ,&nbsp;Aleksandra Karaczewska ,&nbsp;Natalia Karkos ,&nbsp;Wojciech Apoznański","doi":"10.1016/j.sempedsurg.2025.151568","DOIUrl":"10.1016/j.sempedsurg.2025.151568","url":null,"abstract":"<div><h3>Background</h3><div>The aim of the study was an assessment of whether the age of patients with WT could be measured as a risk factor and an analysis of the treatment of patients over 10 years old.</div></div><div><h3>Methods</h3><div>The data of 942 patients treated because of Wilms tumour from 1997 to 2022 were assessed.</div></div><div><h3>Results</h3><div>Patients were divided by age into two groups: group 1 (888 (94,27%) patients age 0–9 years old) and group 2 (54 (5,73%) patients age 10–18 years old). In group 1, there were more patients at higher stage than in group 2 (p&lt;0,05). The histology of low risk in group 1 versus group 2 occurred in 13,4% vs 3,7% patients, of intermediate risk in 66,2% vs 66,7% patients and high risk in 19,9% vs 29,6% patients. Results of treatment were assessed only in group 2 which is a limitation of this study. Overall 62,96% patients survived in this group.</div></div><div><h3>Conclusion</h3><div>Wilms tumour in children 10–18 years old is diagnosed at a higher stage and with worse histology. Overall survival in this age group is lower than in younger children, which is in line with the current literature.</div></div>","PeriodicalId":49543,"journal":{"name":"Seminars in Pediatric Surgery","volume":"38 ","pages":"Article 151568"},"PeriodicalIF":2.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145427175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical outcome and risk factors for recurrence of percutaneous external drainage in treating pediatric pancreatic pseudocysts 经皮外引流治疗小儿胰腺假性囊肿复发的临床结果及危险因素。
IF 2.5 3区 医学 Q3 PEDIATRICS Pub Date : 2025-11-01 DOI: 10.1016/j.sempedsurg.2025.151565
Ken Chen, Shuhao Zhang, Qingjiang Chen

Background

Pediatric pancreatic pseudocysts are rare clinically and there is no consensus on an optimum treatment strategy for it. Here, we aim to evaluate the outcome and efficacy of percutaneous external drainage in treating pediatric pancreatic pseudocysts.

Methods

All 62 patients with pancreatic pseudocysts from January 2012 to December 2021, were included. Patients were divided into conservative treatment group (Group A) and external drainage group (Group B). A retrospective analysis was performed based on clinical manifestation and prognosis.

Results

The maximum transverse diameter of cysts was significantly smaller in group A than group B (⁎⁎⁎P < 0.001). The duration of cystic regression was significantly greater in group A than group B (⁎⁎P = 0.013). The curative rate (complete disappearance of all pseudocysts) was 73.5% (25/34) in group A and 88.9% (24/27) in group B. The effective treatment rate (complete disappearance of all pseudocysts or persistence of asymptomatic pseudocysts) was 85.3% (29/34) in group A and 92.6% (25/27) in group B. The existence of fibrous septa in the cyst was an independent risk factor for cyst recurrence after external drainage (⁎⁎P = 0.022).

Conclusion

Conservative treatment is feasible for small asymptomatic pseudocysts; external drainage was safe and effective for large and symptomatic pseudocysts, while the presence of fibrous septa in cysts should be carefully evaluated before external drainage surgery.
背景:小儿胰腺假性囊肿在临床上很少见,目前对其最佳治疗策略尚无共识。在这里,我们的目的是评估经皮外引流治疗儿童胰腺假性囊肿的结果和疗效。方法:选取2012年1月至2021年12月62例胰腺假性囊肿患者。患者分为保守治疗组(A组)和外引流组(B组)。根据临床表现和预后进行回顾性分析。结果:A组囊肿最大横径明显小于B组(P < 0.001)。A组囊性消退持续时间明显长于B组(P = 0.013)。A组治愈率为73.5% (25/34),b组治愈率为88.9%(24/27)。A组治愈率为85.3% (29/34),b组治愈率为92.6%(25/27)。囊肿内存在纤维间隔是体外引流后囊肿复发的独立危险因素(P = 0.022)。结论:小型无症状假性囊肿保守治疗是可行的;对于大且有症状的假性囊肿,外引流是安全有效的,但在进行外引流手术前应仔细评估囊肿中是否存在纤维间隔。
{"title":"Clinical outcome and risk factors for recurrence of percutaneous external drainage in treating pediatric pancreatic pseudocysts","authors":"Ken Chen,&nbsp;Shuhao Zhang,&nbsp;Qingjiang Chen","doi":"10.1016/j.sempedsurg.2025.151565","DOIUrl":"10.1016/j.sempedsurg.2025.151565","url":null,"abstract":"<div><h3>Background</h3><div>Pediatric pancreatic pseudocysts are rare clinically and there is no consensus on an optimum treatment strategy for it. Here, we aim to evaluate the outcome and efficacy of percutaneous external drainage in treating pediatric pancreatic pseudocysts.</div></div><div><h3>Methods</h3><div>All 62 patients with pancreatic pseudocysts from January 2012 to December 2021, were included. Patients were divided into conservative treatment group (Group A) and external drainage group (Group B). A retrospective analysis was performed based on clinical manifestation and prognosis.</div></div><div><h3>Results</h3><div>The maximum transverse diameter of cysts was significantly smaller in group A than group B (<sup>⁎⁎⁎</sup><em>P</em> &lt; 0.001). The duration of cystic regression was significantly greater in group A than group B (<sup>⁎⁎</sup><em>P</em> = 0.013). The curative rate (complete disappearance of all pseudocysts) was 73.5% (25/34) in group A and 88.9% (24/27) in group B. The effective treatment rate (complete disappearance of all pseudocysts or persistence of asymptomatic pseudocysts) was 85.3% (29/34) in group A and 92.6% (25/27) in group B. The existence of fibrous septa in the cyst was an independent risk factor for cyst recurrence after external drainage (<sup>⁎⁎</sup><em>P</em> = 0.022).</div></div><div><h3>Conclusion</h3><div>Conservative treatment is feasible for small asymptomatic pseudocysts; external drainage was safe and effective for large and symptomatic pseudocysts, while the presence of fibrous septa in cysts should be carefully evaluated before external drainage surgery.</div></div>","PeriodicalId":49543,"journal":{"name":"Seminars in Pediatric Surgery","volume":"38 ","pages":"Article 151565"},"PeriodicalIF":2.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145373221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systematic review and meta-analysis of the effectiveness and safety of conservative versus surgical management in pediatric pancreatic trauma 对儿童胰腺创伤保守治疗与手术治疗的有效性和安全性进行系统回顾和荟萃分析。
IF 2.5 3区 医学 Q3 PEDIATRICS Pub Date : 2025-11-01 DOI: 10.1016/j.sempedsurg.2025.151564
Mateo Londoño Barrientos , Sofia Pinzon Calderon , Carlos Alberto Lopez Zapata , Carlos Andres Delgado Lopez

Background

Pancreatic trauma in the pediatric population is an uncommon but highly morbid injury. Its management remains controversial, with treatment strategies ranging from non-operative management (NOM) to upfront operative management (OM), primarily guided by the patient's hemodynamic stability and the integrity of the main pancreatic duct. This systematic review and meta-analysis aim to elucidate the comparative effectiveness and safety of NOM versus OM for pediatric pancreatic trauma.

Methods

Following PRISMA guidelines, a systematic search was conducted in seven major databases (including PubMed/MEDLINE, EMBASE, and Scopus) up to September 10, 2025. From 320 identified records, 17 observational studies met the eligibility criteria, comprising 1147 patients. A random-effects meta-analysis was performed to calculate pooled Odds Ratios (OR) with 95% Confidence Intervals (CI) for key outcomes, including mortality, overall complications, pancreatic pseudocyst, and fistula. Bayesian analysis was used for corroboration, and the certainty of evidence was assessed using the GRADE framework.

Results

The analysis found no significant difference between NOM and OM for mortality (OR 0.89; 95% CI 0.48–1.66; I²=0%) or overall complications (OR 0.75; 95% CI 0.41–1.38; I²≈41%). However, a significant clinical trade-off emerged for specific complications. NOM was associated with a significantly higher risk of pancreatic pseudocyst (OR 2.56; 95% CI 1.55–4.23; I²=0%). Conversely, NOM was associated with a substantially lower risk of pancreatic fistula compared to OM (OR 0.27; 95% CI 0.11–0.69; I²=0%). Evidence for other secondary outcomes was largely inconclusive due to statistical imprecision. The certainty of evidence for all outcomes was rated as very low.

Conclusion

Non-operative management is a viable and safe primary strategy in selected pediatric patients with pancreatic trauma and does not appear to increase mortality. The therapeutic decision hinges on a crucial trade-off: NOM increases the risk of pseudocyst formation, while OM increases the risk of iatrogenic fistula. Despite the very low certainty of the available evidence—an inherent limitation of trauma research—these findings provide a critical framework for facilitating shared decision-making. Prospective, multi-center registry studies are urgently needed to establish more definitive guidelines.
背景:胰腺创伤在儿童人群中是一种罕见但高度病态的损伤。其治疗仍然存在争议,治疗策略从非手术治疗(NOM)到术前治疗(OM),主要以患者血流动力学稳定性和主胰管的完整性为指导。本系统综述和荟萃分析旨在阐明NOM与OM治疗儿童胰腺创伤的有效性和安全性的比较。方法:按照PRISMA指南,系统检索截至2025年9月10日的7个主要数据库(包括PubMed/MEDLINE、EMBASE和Scopus)。从320份确定的记录中,17项观察性研究符合资格标准,包括1147名患者。进行随机效应荟萃分析,以95%置信区间(CI)计算关键结局的合并优势比(OR),包括死亡率、总并发症、胰腺假性囊肿和瘘管。使用贝叶斯分析进行确证,并使用GRADE框架评估证据的确定性。结果:分析发现NOM和OM在死亡率(OR 0.89; 95% CI 0.48-1.66; I²=0%)和总并发症(OR 0.75; 95% CI 0.41-1.38; I²≈41%)方面无显著差异。然而,对于特定的并发症,一个重要的临床权衡出现了。NOM与胰腺假性囊肿的风险显著升高相关(OR 2.56; 95% CI 1.55-4.23; I²=0%)。相反,与OM相比,NOM发生胰瘘的风险明显较低(OR 0.27; 95% CI 0.11-0.69; I²=0%)。由于统计不精确,其他次要结果的证据在很大程度上是不确定的。所有结果的证据确定性被评为非常低。结论:对于特定的儿童胰腺创伤患者,非手术治疗是一种可行且安全的主要策略,并且似乎不会增加死亡率。治疗决定取决于一个关键的权衡:NOM增加假性囊肿形成的风险,而OM增加医源性瘘的风险。尽管现有证据的确定性非常低——这是创伤研究的固有局限性——但这些发现为促进共同决策提供了一个关键框架。迫切需要前瞻性、多中心注册研究来建立更明确的指导方针。
{"title":"Systematic review and meta-analysis of the effectiveness and safety of conservative versus surgical management in pediatric pancreatic trauma","authors":"Mateo Londoño Barrientos ,&nbsp;Sofia Pinzon Calderon ,&nbsp;Carlos Alberto Lopez Zapata ,&nbsp;Carlos Andres Delgado Lopez","doi":"10.1016/j.sempedsurg.2025.151564","DOIUrl":"10.1016/j.sempedsurg.2025.151564","url":null,"abstract":"<div><h3>Background</h3><div>Pancreatic trauma in the pediatric population is an uncommon but highly morbid injury. Its management remains controversial, with treatment strategies ranging from non-operative management (NOM) to upfront operative management (OM), primarily guided by the patient's hemodynamic stability and the integrity of the main pancreatic duct. This systematic review and meta-analysis aim to elucidate the comparative effectiveness and safety of NOM versus OM for pediatric pancreatic trauma.</div></div><div><h3>Methods</h3><div>Following PRISMA guidelines, a systematic search was conducted in seven major databases (including PubMed/MEDLINE, EMBASE, and Scopus) up to September 10, 2025. From 320 identified records, 17 observational studies met the eligibility criteria, comprising 1147 patients. A random-effects meta-analysis was performed to calculate pooled Odds Ratios (OR) with 95% Confidence Intervals (CI) for key outcomes, including mortality, overall complications, pancreatic pseudocyst, and fistula. Bayesian analysis was used for corroboration, and the certainty of evidence was assessed using the GRADE framework.</div></div><div><h3>Results</h3><div>The analysis found no significant difference between NOM and OM for mortality (OR 0.89; 95% CI 0.48–1.66; I²=0%) or overall complications (OR 0.75; 95% CI 0.41–1.38; I²≈41%). However, a significant clinical trade-off emerged for specific complications. NOM was associated with a significantly higher risk of pancreatic pseudocyst (OR 2.56; 95% CI 1.55–4.23; I²=0%). Conversely, NOM was associated with a substantially lower risk of pancreatic fistula compared to OM (OR 0.27; 95% CI 0.11–0.69; I²=0%). Evidence for other secondary outcomes was largely inconclusive due to statistical imprecision. The certainty of evidence for all outcomes was rated as very low.</div></div><div><h3>Conclusion</h3><div>Non-operative management is a viable and safe primary strategy in selected pediatric patients with pancreatic trauma and does not appear to increase mortality. The therapeutic decision hinges on a crucial trade-off: NOM increases the risk of pseudocyst formation, while OM increases the risk of iatrogenic fistula. Despite the very low certainty of the available evidence—an inherent limitation of trauma research—these findings provide a critical framework for facilitating shared decision-making. Prospective, multi-center registry studies are urgently needed to establish more definitive guidelines.</div></div>","PeriodicalId":49543,"journal":{"name":"Seminars in Pediatric Surgery","volume":"38 ","pages":"Article 151564"},"PeriodicalIF":2.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145394697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Seminars in Pediatric Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1